In COVID19 reporting, there are several data elements that are considered sensitive and thus require special attention to ensure privacy and security. The sensitive COVID19-related data that would warrant privacy and security protections include:

1. Demographic information: Demographic information about a patient, such as their name, address, and date of birth, is sensitive information that should be protected to prevent unauthorized access or disclosure.
2. Test results: COVID19 test results are sensitive medical information that should be protected to prevent unauthorized access or disclosure. This information may be used to track the spread of the virus and identify areas of concern, but it must be shared and accessed only by authorized parties.
3. Treatment and care information: Treatment and care information, including patient's COVID19 symptoms, medications and other therapies, is sensitive medical information that should be protected to prevent unauthorized access or disclosure. This information can be used to provide better care for patients, but it must be shared and accessed only by authorized parties.
4. Vaccination status: Information about a patient's vaccination status is also sensitive medical information that should be protected to prevent unauthorized access or disclosure. This information can be used to track vaccination rates and identify areas of concern, but it must be shared and accessed only by authorized parties.

There are a couple of Privacy and security measures that could be instituted to protect these sensitive data elements. These may include access controls, encryption, and other security measures to protect patient data from unauthorized access or disclosure.

• Data access controls: Access controls should be implemented to ensure that only authorized individuals can access and use patient data. This can include limiting access to data based on job function or responsibility and implementing user authentication protocols.
• Data encryption: Encryption should be implemented to protect sensitive patient data, such as personal health information (PHI), from unauthorized access or interception. This can include encryption of data in transit and data at rest.
• Audit logs: Systems used for data collection and reporting should have audit logs of the various transactions
• Data minimization: One of the best practices for most program work is to only collect and use the minimum amount of patient data necessary for the intended purpose. This can help to limit the risk of unauthorized access or exposure of sensitive patient data.
• Risk assessments: Regular risk assessments should be conducted to identify potential security risks and vulnerabilities and appropriate mitigation measures should be put in place to address them.
• Compliance with regulatory requirements: The COVID19 reporting should comply with relevant privacy and security regulations, such as HIPAA and GDPR. Compliance may include implementing appropriate technical and organizational safeguards to protect patient data.